Loophole in patent law brings ‘miracle drug’ to patients who can’t afford it

A generic version of a groundbreaking cystic fibrosis drug, produced in Bangladesh, has emerged thanks to a loophole in patent law, potentially offering a lifeline to families worldwide struggling to afford the medication. This development underscores the ongoing debate about drug pricing and access, highlighting how legal exploits can sometimes lead to more equitable healthcare solutions. While the availability of this generic drug could greatly benefit patients, it also raises questions about the balance between pharmaceutical innovation and patient affordability.